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The aim of this study was to evaluate the effect of dissolution medium, rotation speed and compaction 
pressure on the intrinsic dissolution rate (IDR) of the antihypertensive drug amlodipine besylate, using 
the rotating disk method. Accordingly, a fractional factorial design (33-1) was used, employing dissolution 
media (water, phosphate buffer pH 6.8 and HCl 0.1 M), rotation speed (50, 75 and 100 rpm), and 
compaction pressure (1000, 1500 and 2000 psi) as independent variables. The assays were randomized 
and statistically compared using the Statistica® 11 software program. Significance testing (ANOVA) 
indicated that the dissolution medium had a considerable impact on the IDR of amlodipine besylate. 
Analysis of the linear and quadratic components of the variables led to the proposition of a mathematical 
model that describes the IDR as a function of the parameters studied. Conversely, the levels of compaction 
pressure and rotation speed employed during experimental planning were less relevant, especially when 
the assay was conducted in the HCl 0.1 M medium.
Uniterms: Amlodipine besylate/intrinsic dissolution. Biopharmaceutical classification system. Drugs/
experimental design. Antihypertensive drugs/Amlodipine besylate.
A finalidade do presente trabalho foi avaliar o efeito do meio de dissolução, velocidade de rotação e pressão 
de compactação na velocidade de dissolução intrínseca (VDI) do fármaco anti-hipertensivo besilato de 
anlodipino, usando o método do disco rotativo. Dessa forma, foi utilizado um planejamento experimental 
do tipo fatorial facionado (33-1) utilizando como variáveis independentes o meio de dissolução (água, 
HCl 0,1M e tampão fosfato pH 6,8), velocidade de rotação (50, 75 e 100 rpm) e pressão de compactação 
do fármaco (1000, 1500 e 2000 psi). Os ensaios foram randomizados e comparados estatisticamente 
pelo software Statistica® 11. A análise de variância (ANOVA) indicou que o meio de dissolução exerce 
considerável impacto na VDI do besilato de anlodipino. A análise das variáveis em seus componentes 
lineares e quadráticos permitiu a proposição de um modelo matemático que descreve a VDI em função 
dos parâmetros estudados. Por outro lado, os níveis de pressão de compactação e velocidade de rotação 
empregados exercem efeito menos relevantes, especialmente quando o ensaio é conduzido em HCl 0,1 M.
Unitermos: Besilato de anlodipino/dissolução intrínseca. Sistema de classificação biofarmacêutica. 
Fármacos/delineamento experimental. Fármacos/anti-hipertensivos/ Besilato de anlodipino.
INTRODUCTION
Intrinsic dissolution is the study of the dissolution 
and release of a drug from a surface consisting of the drug 
itself, under constant agitation, pH and ionic strength of 
the medium. This release can be expressed numerically 
by a value called the intrinsic dissolution rate (IDR), 
characteristic that allows the solubility of a given active 
pharmaceutical ingredient to be assessed (Healy et al., 
2002).
With regards to the solubility test - executed, for 
example, by the shake-flask method (Baka, Comer, 
Tacáks-Novák, 2008) - the intrinsic dissolution test has 
the advantages of requiring a smaller quantity of drug 
and a shorter assay time. Furthermore, the variability of 
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results is usually less significant, thus enabling a better 
description of the phenomenon. Finally, the in vivo / in 
vitro correlation can be better defined, since it measures 
the rate at which a drug is dissolved (Issa, Ferraz, 2011; 
Yu et al., 2004).
Accordingly, intrinsic dissolution is an important 
tool for the physicochemical characterization of drugs in 
their solid states and constitutes a test allowing intervention 
in the dissolution behavior of the active pharmaceutical 
ingredient in certain physiological environments, 
regardless of the action of excipients in the formulation. 
For this purpose, rotary disks (Wood’s apparatus) or fixed 
disks can be used as intrinsic dissolution apparatuses 
(Stelle, Austin, 2009; Viegas et al., 2001).
However, it is important to consider that the intrinsic 
dissolution rate can be affected by many factors, such 
as the crystalline properties of the drug (occurrence 
of polymorphism and solvation), the conditions of the 
dissolution medium (temperature, ionic strength and 
viscosity) and hydrodynamics, dictated largely by the 
stirring rate (Issa, Ferraz, 2011; Sehic et al., 2010; Stelle, 
Austin, 2009; Zakeri-Milani et al., 2009; Bartolomei et 
al., 2006).
The influence of these factors on the IDR can be 
studied by means of a suitable statistical analysis. One 
widely used method consists of changing the levels of the 
variable under study, whilst keeping the others completely 
constant (one factor at a time). Although it is possible 
to evaluate the effect of a particular factor on a specific 
response, this procedure requires a large number of tests, 
which can prove inefficient and economically unfeasible 
(Kincl, Turk, Vrecer, 2005).
In this sense, experimental design is a promising 
technique, since it allows the variables that most influence 
the response of a phenomenon to be determined. In 
the specific case of fractional factorial designs, the 
relationship among different factors can be explained by 
the response surface method, which allows us to assess the 
factors with the greatest impact on the studied response, 
thus enabling the process to be optimized for improved 
productivity and efficiency. The advantage of applying 
experimental design lies in the rationalization of testing, 
cost reduction and more satisfactory agreement between 
expected and obtained values (Box, Hunter, Hunter, 2005; 
Montgomery, 2001).
Currently, there are few studies in the related 
literature that statistically evaluate the influence of 
parameters employed (at different levels) in dissolution 
testing, indicating that this important tool is not yet widely 
used in the pharmaceutical area (Issa et. al., 2013; Polonini 
et al., 2011; Parojčić et al., 2001).
A m l o d i p i n e  b e s y l a t e  ( m e t h y l  e t h y l 
2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-
1,4-dihydropyridine-3,5-dicarboxylate), empirical 
formula C20H25ClN2O5 , and molecular weight 408.9 
g.mol-1, is an antihypertensive drug of the third generation 
of dihydropyridines, introduced into therapy in the 
1980s by Pfizer Inc., under the brand name Norvasc®. Its 
structure (Figure 1) contains a long chain called 2-amino 
ethyl methyl, which protects the dihydropyridine ring 
from oxidation caused by the enzyme cytochrome P450 
(Katoh et al., 2000). Despite being a highly soluble drug, 
there is no consensus about which class it belongs to in 
the Biopharmaceutical Classification System, due to its 
intermediate bioavailability, which is 65% (Lindenberg, 
Kopp, Dressman, 2004).
Moreover, there is no record in the literature of 
any intrinsic dissolution tests involving this drug or what 
parameters may influence its IDR. Thus, the aim of this 
study was to evaluate the effect of dissolution medium, 
rotation speed and compaction pressure on the intrinsic 
dissolution rates of the drug amlodipine besylate, using 
the rotating disk method.
MATERIAL AND METHODS
Raw material
A sample of the antihypertensive drug amlodipine 
besylate (Cadila Healthcare, Gujarat, India) was used for 
testing. The API, in the form of raw material, was within 
its use-by date and properly protected from light in suitable 
packaging.
Experimental design
Intrinsic dissolution tests were planned with a 
fractional factorial design (33-1), in which three factors 
were stipulated (rotation speed, medium and compression 
pressure), each having three levels, stipulated as -1, 0 and 
+1, in accordance with Table I.
FIGURE 1 – Chemical structure of amlodipine.
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Accordingly, a set of 12 experiments was generated 
(9 from the fractional factorial design and 3 taking into 
account the central levels of the variables), as shown in 
Table II. Tests were fully randomized in order to eliminate 
any bias in results. The effects of interaction among the 
factors were not included in the model, since such a 
procedure would be of more use in a full factorial study (in 
which all 27 possible combinations would be evaluated), 
which was beyond the scope of this investigation.
Finally, the influence of the variables was analyzed 
by means of statistical calculations, including analysis 
of variance (ANOVA), Pareto charts, media and surface-
response graphs, all carried out with the Statistica 11.0 
software program (Statsoft, Tulsa, USA).
TABLE I - Independent variables (factors) and levels used in the 
experimental design for intrinsic dissolution tests of amlodipine 
besylate
Factors
Levels
-1 0 +1
Dissolution 
medium
Phosphate 
buffer pH 6.8
Water HCl 0.1M
 Compaction 
pressure (psi)
1000 1500 2000
Rotation speed 
(rpm)
50 75 100
TABLE II - Description of assays using coded levels (-1, 0, +1) 
for each of the factors employed in the fractional design for 
intrinsic dissolution tests of amlodipine besylate
Assay Compaction Pressure
Dissolution 
medium
Rotation
Speed
1 -1 -1 -1
2 -1  0 +1
3 -1 +1  0
4  0 -1 +1
5  0  0  0
6  0 +1  -1
7 +1 -1  0
8 +1  0  -1
9 +1 +1 +1
10  0  0  0
11  0  0  0
12  0  0  0
Intrinsic dissolution
Intrinsic Dissolution tests were carried out on a VK 
7010 dissolution apparatus (Varian Inc., Palo Alto, CA, 
USA), to which rotating discs containing about 250 mg 
of the drug, previously compressed by a hydraulic press 
(American Lab, Charqueada, SP, Brazil), were coupled. 
Each assay was performed in triplicate within vessels 
containing 900 mL of medium. Samples were collected 
at 5, 10, 15, 30, 45, 60, 90, 120, 150 and 180 minutes and 
quantified by ultraviolet spectrophotometry in a Cary 50 
UV-Vis spectrophotometer (Varian Inc., Palo Alto, CA, 
USA), at a wavelength of 237 nm.
IDR values were obtained by plotting the amount 
of drug dissolved (mg) against time (minutes) on graphs. 
The slope of the curves yielded the dissolution rate of the 
drug in mg.min-1, which, when divided by the surface 
area of the compressed drug (0.5 cm2), gave the IDR of 
amlodipine besylate, according to Equation 1 (United 
States Pharmacopeia, 2012).
 IDR = α/A (Equation 1)
•	 IDR = intrinsic dissolution rate (mg.cm-2.min-1)
•	 α	= slope of the amount of drug dissolved x time 
(mg.min-1)
•	 A = surface area of the compressed drug (0.5 cm2)
RESULTS AND DISCUSSION
Table III shows the IDR values obtained. It can 
be noted that the linear regression coefficients obtained 
were satisfactory, with values greater than or equal to 
0.99. Furthermore, the values suggest that amlodipine 
besylate is a highly-soluble drug, according to the 
Biopharmaceutical Classification System.
Figure 2 plots the linear regression of the amount 
of API dissolved (mg) against time (min) required in 
order to obtain the dissolution rate of the drug. Some 
assays lasted less than three hours due to detachment of 
the compressed drug from the apparatus matrix. Thus, 
in order to calculate the IDR of amlodipine besylate, the 
time that the compressed drug remained in the matrix was 
also considered. Finally, the third test was not completed 
because the compressed drug detached right at the 
beginning of the assay. To enable statistical analysis, the 
IDR was considered to be greater than 5 mg.cm-2.min-1 in 
this case.
Table IV shows the estimated regression coefficients 
and significance tests of the components of the factors 
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studied. It appears that the linear term of the pressure and 
rotational speed, as well as linear and quadratic terms 
of the dissolution medium, are those comprising the 
mathematical model that explains the intrinsic dissolution 
rate of amlodipine besylate (Equation 2).
IDR(Amlodipine) = 1.400 – 0.773 (CP) + 0.074 (CP)2 +  
1.784 (DM) – 0.628 (DM)2 – 0.708 (RS) +0.356 (RS)2 
  (Equation 2)
where: CP = compaction pressure; DM = dissolution 
medium; RS = rotation speed.
Analysis of variance of the factors (taking into 
account the combination of linear and quadratic effects) 
showed that the dissolution medium was the variable with 
the greatest impact on the IDR of amlodipine besylate 
(Table V).
The Pareto chart (Figure 3) is consistent with the 
result obtained in the analysis of variance. It is possible 
to ascertain that, although the linear components of 
compression pressure and rotation speed exert an impact 
on the IDR (which explains the significant values found 
for these parameters, from a statistical standpoint), the 
effect caused by the dissolution medium is much more 
pronounced when compared to the other factors.
Additionally, the media graph (Figure 4) shows 
that the IDR of amlodipine besylate was not subject to 
large variations when either water or phosphate buffer pH 
6.8 is used as a dissolution medium. However, there is a 
significant increase in the IDR value when HCl 0.1 M is 
employed as a medium.
As s ta ted  ear l ie r,  amlodip ine  besyla te  i s 
highly-soluble in aqueous media, according to the 
Biopharmaceutics Classification System. However, 
the greatest IDR values were obtained when 0.1 M 
HCl was used as a dissolution medium, even causing 
the compressed material to loosen, regardless of the 
compaction pressure used (as observed in assays E3, E6 
and E9). This behavior is due to the basic property of 
amlodipine besylate (pKa=8.7), indicating that it is much 
TABLE III - IDR values obtained for each assay, with the 
respective linear regression coefficients (R2) 
Assay IDR  (mg.cm-2.min-1) R
2
1 1.143 0.994
2 0.229 0.999
3 > 5 *
4 0.223 0.995
5 0.233 0.998
6 4.591 0.998
7 0.319 0.996
8 0.192 0.997
9 1.221 0.995
10 0.187 0.999
11 0.199 0.999
12 0.264 0.998
* Regression coefficient not obtained due to detachment of the 
compressed drug in the beginning of the test.
FIGURE 2 – Linear regression of the points pertaining to the amount of amlodipine besylate dissolved against time, in the intrinsic 
dissolution tests carried out according to Table III.
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TABLE IV - Estimated regression coefficients and significance tests of linear (L) and quadratic (Q) components of the factors studied. 
Result is significant for p <0.05 (bold)
Components Coefficient P Standard error Confidence level (-95%)
Confidence level 
(+95%)
Intercept 1.40 0.000 0.20 0.89 1.91
Compaction pressure (L) -0.77 0.028 0.25 -1.43 -0.12
Compaction pressure (Q) 0.07 0.723 0.20 -0.43 0.58
Dissolution medium (L) 1.78 0.000 0.23 1.18 2.39
Dissolution medium (Q) -0.62 0.032 0.21 -1.18 -0.07
Rotation speed (L) -0.70 0.038 0.25 -1.36 -0.05
Rotation speed (Q) 0.36 0.200 0.20 -0.31 0.71
TABLE V – Significance tests (ANOVA) for the factors studied. Result is significant for p < 0.05 (bold)
Factor Sum of squares Degrees of freedom Mean of squares F p
Compaction pressure 3.64 2 1.82 4.67 0.071
Dissolution medium 24.37 2 12.18 31.26 0.001
Rotation speed 3.41 2 1.70 4.38 0.079
Error 1.95 5 0.38 ** **
FIGURE 3 - Pareto chart representing the analysis of variance 
for linear (L) and quadratic (Q) components of the parameters 
studied. Results are significant for p > 0.05.
FIGURE 4 – Mean values of amlodipine besylate IDR 
(mg.cm-2.min-1). Error bars indicate the standard deviation of 
the media.
more soluble in an acidic medium (Shoin et al., 2010; van 
Zwieten, 1994).
Analysis of the media graph enables us to infer 
that the compaction pressure has some influence on the 
dissolution of the material, but has no significant impact on 
the IDR of amlodipine besylate. In all the media studied, 
it can be noted that the 1000 psi compression pressure 
yielded the highest value for the intrinsic dissolution rate, 
which supports the theory that the dissolution medium 
can easily penetrate between the particles of this structure, 
increasing its wettability and hence facilitating dissolution 
of the compound. However, it is important to mention that, 
from a statistical standpoint, the results yielded by analysis 
of variance do not enable us to reject the null hypothesis; 
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i.e., that there is no relationship between compaction 
pressure and intrinsic dissolution rate.
The viability of the fractional factorial design (33-1) 
was ascertained through a residual analysis where a 
normal probability plot of the errors was designed, based 
on the residual values as a function of the expected IDR 
values. The points corresponding to the residual errors are 
randomly distributed near the line (Figure 5), indicating 
the homogeneity of variances and validity of the fractional 
factorial model proposed for this study (Montgomery, 
2001).
A comparison of the influence of the factors on the 
IDR, considered two by two, is represented in the surface-
response graphs (Figure 6). It is evident that the lower 
the compaction pressure, the greater the tendency of the 
drug to loosen and solubilize, thus increasing the IDR. 
However, when compared to the dissolution medium, the 
compaction pressure itself does not seem significant, since 
the IDR increases significantly at all points when the drug 
is tested with HCl 0.1 M, which represents the highest 
level of the dissolution medium variable.
Finally, a comparison of the other two factors shows 
that the lower the compaction pressure and the higher the 
speed, the more the IDR of amlodipine besylate increases. 
However, the absence of a sharp curvature demonstrates 
that these factors are not significant in the response of 
the dependent variable, corroborating the results of the 
statistical analyses previously mentioned.
Based on these results, it is possible to establish 
the most favorable conditions for assessing the intrinsic 
dissolution rate of amlodipine besylate. The dissolution 
medium consisting of water only had the lowest IDR 
variability, which is especially evident in the media graph 
FIGURE 5 - Normal probability plot of errors, based on the 
residuals obtained from the ID values for amlodipine besylate.
FIGURE 6 - Surface-response graphs for the IDR of amlodipine besylate compared to the studied factors (A) dissolution medium 
x compaction pressure, (B) dissolution medium x rotation speed, and (C) compaction pressure x rotation speed.
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(Figure 3). Accordingly, using this dissolution medium at 
any pressure (1000 to 2000 psi) and speed (50-100 rpm) 
ensures the compacted drug does not disintegrate during 
intrinsic dissolution assay, maintaining a constant surface 
area and enabling a suitable investigation of the IDR of 
amlodipine besylate.
CONCLUSION
Based on these results, the IDR of amlodipine 
besylate was found to be affected mainly by the dissolution 
medium used for testing. The levels of compaction 
pressure and rotation speed employed had less impact on 
the dependent variable and, according to the statistical 
data, are not significant factors in the IDR of the drug.
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